Saleem, Hamza <br/><br/>
The TICking clock of EGFR therapy resistance in glioblastoma: Target Independence or target Compensation.  [electronic resource] 

 -  Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy  03 2019 
 - 29-37 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1532-2084 
<br/><br/><label>Standard No.: </label>10.1016/j.drup.2019.04.002  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Brain Neoplasms--drug therapy<br/>Carcinogenesis--drug effects<br/>Drug Resistance, Neoplasm<br/>ErbB Receptors--antagonists & inhibitors<br/>Glioblastoma--drug therapy<br/>Humans<br/>Molecular Targeted Therapy--methods<br/>Mutation<br/>Oncogenes--genetics<br/>Protein Kinase Inhibitors--pharmacology<br/>Proto-Oncogene Proteins c-met--metabolism<br/>Proto-Oncogene Proteins c-sis--metabolism<br/>Receptor, IGF Type 1--metabolism<br/>Signal Transduction--drug effects<br/>Treatment Outcome